Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Volume 61, Issue 6, Pages (December 2014)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
The origin of cancer stem cells
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Volume 61, Issue 5, Pages (November 2014)
Mesenchymal stromal cell therapy for liver diseases
Volume 69, Issue 2, Pages (August 2018)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma  André Lechel, Michael P. Manns, K.Lenhard Rudolph 
The progenitor cell dilemma: Cellular and functional heterogeneity in assistance or escalation of liver injury  Veronika Lukacs-Kornek, Frank Lammert 
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Volume 44, Issue 5, Pages (May 2006)
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Two Fresh Streams to Fill the Liver’s Hepatocyte Pool
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 45, Issue 4, Pages (October 2006)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 50, Issue 4, Pages (April 2009)
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Volume 56, Issue 6, Pages (June 2012)
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
Macrophage heterogeneity in liver injury and fibrosis
The dynamic biliary epithelia: Molecules, pathways, and disease
The use of hemospray in portal hypertensive bleeding; a case series
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Statins: Old drugs as new therapy for liver diseases?
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
The origin of biliary strictures after liver transplantation: Is it the amount of epithelial injury or insufficient regeneration that counts?  Negin Karimian,
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 64, Issue 6, Pages (June 2016)
Presentation transcript:

Biliary-derived hepatocytes in chronic liver injury: Bringing new troops to the battlefield?  Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology  Volume 70, Issue 6, Pages 1051-1053 (June 2019) DOI: 10.1016/j.jhep.2019.03.015 Copyright © 2019 Terms and Conditions

Fig. 1 Rodent models of chronic liver disease, in which the biliary-derived hepatocytes contribute to parenchymal regeneration. In chronic injury, when the native hepatocytes are able to proliferate normally, the biliary-derived hepatocytes contribute minimally to parenchymal restoration even in injury scenarios with widespread hepatocyte loss (1.). In chronic injury, when the capacity of the native hepatocytes to proliferate is impaired, the biliary-derived hepatocytes contribute significantly to parenchymal regeneration (2.). In prolonged chronic injury and compromised native hepatocyte proliferation, the biliary-derived hepatocytes contribute to parenchymal restoration. Importantly, the damaged, native hepatocytes are susceptible to malignant transformation (3.). Journal of Hepatology 2019 70, 1051-1053DOI: (10.1016/j.jhep.2019.03.015) Copyright © 2019 Terms and Conditions